Results 61 to 70 of about 12,023 (229)

A possible role of GDNF expression by which cabergoline use affects corpus callosum

open access: yesJournal of Pediatric and Neonatal Individualized Medicine, 2018
A variety of malformations have been associated with cabergoline use during gestation. Recently we had a preterm male infant referred to our Neonatal Intensive Care Unit diagnosed with corpus callosum agenesis confirmed by brain ultrasound and brain ...
Georgios Mitsiakos, Anastasia Gkampeta
doaj   +1 more source

Triage and care for women with symptoms or diagnosis of pregnancy loss between 14 + 0 and 21 + 6 weeks' gestation

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 172, Issue 1, Page 25-50, January 2026.
Abstract Mid‐trimester pregnancy loss (MTL), defined as a pregnancy loss occurring between 14 + 0 and 21 + 6 weeks of gestation, causes significant physical and emotional distress to women and presents clinical challenges to healthcare professionals. It is acknowledged that in low‐resource settings, this guideline might be applicable to births up to 28 
Caroline E. Fox   +46 more
wiley   +1 more source

Stability of Medications Administered via Enteral Feeding Tubes: A Systematic Review

open access: yesClinical and Translational Science, Volume 19, Issue 1, January 2026.
The graphical abstract for the stability of medicatioins administred via enteral feeding tube: A systematic review ((PROSPERO, registration number: CRD42024580820)). ABSTRACT Feeding tubes are essential for patients unable to maintain adequate oral intake, serving multiple purposes including nutrition delivery and medication administration.
Lena Alodat   +3 more
wiley   +1 more source

Cabergoline for preventing ovarian hyperstimulation syndrome in women at risk undergoingin vitro fertilization/intracytoplasmic sperm injection treatment cycles: A randomized controlled study

open access: yesAvicenna Journal of Medicine, 2015
Background: Ovarian hyperstimulation syndrome (OHSS) is the most serious and potentially life-threatening iatrogenic complication associated with ovarian stimulation during assisted reproductive technology protocols. The aim of this study was to evaluate
Niyazi Kilic   +5 more
doaj   +1 more source

Chronic cluster headache and the pituitary gland [PDF]

open access: yes, 2016
Background: Cluster headache is classified as a primary headache by definition not caused by an underlying pathology. However, symptomatic cases of otherwise typical cluster headache have been reported.
DE PUE, ANNELIEN   +2 more
core   +1 more source

Development of a health‐related quality‐of‐life assessment tool for equines with pituitary pars intermedia dysfunction

open access: yesEquine Veterinary Journal, Volume 58, Issue 1, Page 190-202, January 2026.
Abstract Background Clinical signs of pituitary pars intermedia dysfunction (PPID) are frequently mistaken for ‘normal’ ageing and may not be optimally assessed. Objective quality of life (QoL) assessment could improve clinical decision‐making. Objectives To develop an owner‐reported health‐related quality‐of‐life (HRQoL) assessment tool for equines ...
Aline Bouquet   +4 more
wiley   +1 more source

Effect of ondansetron for preventing of ovarian hyperstimulation syndrome: in an experimental rat model

open access: yesGynecological Endocrinology, 2022
Objective: Ovarian hyperstimulation syndrome is an iatrogenic condition that occurs in the treatment of infertility. There is no specific treatment available for OHSS.
Şükrü Bakırcı   +5 more
doaj   +1 more source

Emerging drugs for Cushing's disease [PDF]

open access: yes, 2015
INTRODUCTION: Considering the effects of uncontrolled hypercortisolism on morbidity and mortality, there is a clear need for effective medical therapy for patients with Cushing's disease (CD).
Grossman, AB, Guelho, DL
core   +1 more source

Home - About - Disclaimer - Privacy